Chen, L. Y., Aleman, A., Larrayoz, M., Chiu, H., Zhao, J., Oekelen, O. V., Kelly, G., Kim-Schulze, S., Laganà, A., Jagannath, S., Chow, T. T., Lozano, T., Lasarte, J. J., Hamley, J. C., Baker, W., Ebert, B. L., Oppermann, U., Amatangelo, M. D., Gandhi, A. K., Hagner, P. R., Martínez-Climent, J. A., Gooding, S., Milne, T. A., Parekh, S. (2026). Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies. Blood. https://doi.org/10.1182/blood.2025030891